Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence - Wikidata - awgldk - TriplyDB

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

http://www.wikidata.org/entity/Q58099097

about

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

http://www.wikidata.org/entity/Q58099097

description

article publié dans la revue scientifique Scientific Reports

@fr

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@en

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@nl

type

label

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@en

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@nl

prefLabel

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@en

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@nl

P1433

Q58099097-A5B20192-032F-483C-A0AE-3A6005E25A72

P1476

Q58099097-F8BB0377-0726-4629-8BB1-A6345CE87FDD

P2093

Q58099097-73299126-7028-4F13-AF01-11C81FCB2071

P2860

Q58099097-023928B0-D039-4862-9DFC-668ADEBEF2A3

Q58099097-0E593771-98B9-47FB-8214-87CC6D524E8D

Q58099097-0ED22020-AEB5-422C-ACDD-4910F4F314F1

Q58099097-123956E5-8E5B-4297-B2DE-BA1AA2D3058F

Q58099097-1A8BD5CB-D981-4F55-92EE-1A7E2AE697FE

Q58099097-214218E4-C87B-42E0-9797-1D43F0439731

Q58099097-2C54FD51-9177-449F-964A-137BE08D90A9

Q58099097-2FBB8AB9-D926-4740-B5CE-F6ED6B11183D

Q58099097-45840401-E003-4740-B086-5B45FB1BA855

Q58099097-5812A18F-FDE2-4CB9-B493-86A3048B765D

P304

Q58099097-A9482E56-C978-43A5-B551-39B92B1ADCEA

P31

Q58099097-380dcce7-1940-4d28-a357-c75e7f602dce

Q58099097-ED69D680-6863-4B72-9046-B5AC4E33C3C9

P356

Q58099097-A9FEA84E-E45C-4D4F-B2C2-8B876CDD1B85

P407

Q58099097-75C08EDF-079B-4093-ACDC-C243DFCE3104

P433

Q58099097-7BDDE88D-A3ED-4952-BC34-A5CF13B45DC9

P478

Q58099097-BBC527E9-8D94-462C-8915-573AF7C1D001

P50

Q58099097-68CFECFF-404A-47C6-9FE8-C6B301012525

Q58099097-BBD72C83-711B-4D62-B554-833FF324D3F8

P577

Q58099097-DF417B75-4228-4C43-8498-A71FDCDCCF3C

P698

Q58099097-E9714FB6-928A-486A-B263-FFD356089061

P932

Q58099097-EBBEDC9B-922D-4CF8-87CE-AD6C25E1B795

P356

S41598-018-34293-Y

P1433

Scientific Reports

P1476

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence

@en

P2093

Pei-Tzu Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis.

Risk of Suicidality in People with Psoriasis: A Systematic Review and Meta-Analysis of Cohort Studies.

Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Cost-efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system.

Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.

Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.

P304

16068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-34293-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30375427

http://www.w3.org/2001/XMLSchema#string

P932

6207685

http://www.w3.org/2001/XMLSchema#string